Anita Fauchier serves as VP, Regulatory Affairs in the Allergan R&D Organization. Currently, her team supports the extensive Aesthetics portfolio including iconic global brands such as BOTOX, Juvéderm, and CoolSculpting.
With nearly 35 years industry experience, she has supported the development and commercialization of small molecules, biologics, medical devices, HCT/Ps, OTCs and cosmetics for multiple therapeutic areas. She has served as the regulatory liaison to multiple health authorities and notified bodies worldwide.
Prior to Allergan, she was VP Regulatory Affairs at Palladio Biosciences where she supported global clinical trials for a rare kidney disease. She has also served as the Global Head of Regulatory at Smith + Nephew while managing a global regulatory affairs team and more than 50 product families.
She speaks French and has lived in Paris, France while at SANOFI. She currently resides in Texas.
We create the products and technologies that drive the advancement of aesthetic medicine.
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?
